BridgeMD
New treatment option for Friedreich's Ataxia
Official title Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.
ClinicalTrials.gov ID: NCT07095062
What this study is testing
- What it's testing
- Prospective, exploratory, multicenter pilot study investigating the structural and functional connectome in patients with Friedreich's Ataxia (FRDA) using high-density electroencephalogram (HD-EEG). The aim is to identify neurophysiological biomarkers and analyze the relationship between cortical connectivity, cognitive functioning, and clinical severity, particularly in response to rehabilitation treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 60
You may be able to join if
- age between 8 and 60 years;
- genetic diagnosis of FRDA: presence of guanine-adenine trinucleotide (GAA) expansion in the two alleles of the fratassin gene, GAA1 and GAA2;
- score on the Scale for the Assessment and Rating of Ataxia (SARA) \< 30;
- ability to take part in a neuropsychological assessment in Italian.
You likely can't join if
- age different from the range 8-60 years;
- diagnosis of acquired ataxia or other genetic ataxias;
- SARA scale score ≥ 30;
- inability to take part in an Italian-language neuropsychological assessment
The study team makes the final eligibility decision.
Where it's taking place
- Conegliano, Treviso, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Conegliano, Treviso, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.